BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2162247)

  • 1. Voltage-operated calcium channels in small cell lung carcinoma cell lines: pharmacological, functional, and immunological properties.
    Sher E; Pandiella A; Clementi F
    Cancer Res; 1990 Jul; 50(13):3892-6. PubMed ID: 2162247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies omega-conotoxin and adenosine.
    De Aizpurua HJ; Lambert EH; Griesmann GE; Olivera BM; Lennon VA
    Cancer Res; 1988 Sep; 48(17):4719-24. PubMed ID: 2457429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.
    Meriney SD; Hulsizer SC; Lennon VA; Grinnell AD
    Ann Neurol; 1996 Nov; 40(5):739-49. PubMed ID: 8957015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
    Leys K; Lang B; Johnston I; Newsom-Davis J
    Ann Neurol; 1991 Mar; 29(3):307-14. PubMed ID: 1645944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phoneutria nigriventer omega-Phonetoxin IIA: a new tool for anti-calcium channel autoantibody assays in Lambert-Eaton myasthenic syndrome.
    Martin-Moutot N; Haro Ld; Santos RG; Mori Y; Seagar M
    Neurobiol Dis; 2006 Apr; 22(1):57-63. PubMed ID: 16289869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.
    Johnston I; Lang B; Leys K; Newsom-Davis J
    Neurology; 1994 Feb; 44(2):334-8. PubMed ID: 8309586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines.
    Codignola A; Tarroni P; Clementi F; Pollo A; Lovallo M; Carbone E; Sher E
    J Biol Chem; 1993 Dec; 268(35):26240-7. PubMed ID: 8253745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voltage-sensitive calcium channels in a human small-cell lung cancer cell line.
    Pancrazio JJ; Oie HK; Kim YI
    Acta Physiol Scand; 1992 Apr; 144(4):463-8. PubMed ID: 1318636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. omega-Conotoxin-sensitive, voltage-operated Ca2+ channels in insulin-secreting cells.
    Sher E; Biancardi E; Pollo A; Carbone E; Li G; Wollheim CB; Clementi F
    Eur J Pharmacol; 1992 Jun; 216(3):407-14. PubMed ID: 1330583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional expression of a rapidly inactivating neuronal calcium channel.
    Ellinor PT; Zhang JF; Randall AD; Zhou M; Schwarz TL; Tsien RW; Horne WA
    Nature; 1993 Jun; 363(6428):455-8. PubMed ID: 8389006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
    Waterman SA; Lang B; Newsom-Davis J
    Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. omega-Conotoxin binding sites and regulation of transmitter release in cerebellar granule neurons.
    Elster L; Saederup E; Schousboe A; Squires RF
    J Neurosci Res; 1994 Nov; 39(4):424-9. PubMed ID: 7884821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies bind solubilized calcium channel-omega-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome.
    Lennon VA; Lambert EH
    Mayo Clin Proc; 1989 Dec; 64(12):1498-504. PubMed ID: 2557495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity of omega-conotoxin GVIA for n-type calcium channels in rat isolated small mesenteric arteries.
    Whorlow SL; Angus JA; Wright CE
    Clin Exp Pharmacol Physiol; 1996 Jan; 23(1):16-21. PubMed ID: 8713491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum.
    Arsac C; Raymond C; Martin-Moutot N; Dargent B; Couraud F; Pouget J; Seagar M
    Ann Neurol; 1996 Nov; 40(5):695-700. PubMed ID: 8957009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-voltage-gated calcium channel antibodies in the Lambert-Eaton myasthenic syndrome].
    Motomura M; Suenaga A; Matsuo H; Tsujihata M; Nagataki S
    Rinsho Shinkeigaku; 1994 Oct; 34(10):980-4. PubMed ID: 7834958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome.
    Fukuda T; Motomura M; Nakao Y; Shiraishi H; Yoshimura T; Iwanaga K; Tsujihata M; Eguchi K
    Ann Neurol; 2003 Jan; 53(1):21-8. PubMed ID: 12509844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of omega-conotoxin-sensitive voltage-operated calcium channels in human neuroblastoma cells: modulation by cell differentiation and anti-channel antibodies.
    Passafaro M; Clementi F; Sher E
    J Neurosci; 1992 Sep; 12(9):3372-9. PubMed ID: 1326605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and pharmacological characterization of omega-grammotoxin SIA, a novel peptide inhibitor of neuronal voltage-sensitive calcium channel responses.
    Lampe RA; Defeo PA; Davison MD; Young J; Herman JL; Spreen RC; Horn MB; Mangano TJ; Keith RA
    Mol Pharmacol; 1993 Aug; 44(2):451-60. PubMed ID: 8394998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional evaluation of inhibition of autonomic transmitter release by autoantibody from Lambert-Eaton myasthenic syndrome.
    Houzen H; Hattori Y; Kanno M; Kikuchi S; Tashiro K; Motomura M; Nakao Y; Nakamura T
    Ann Neurol; 1998 May; 43(5):677-80. PubMed ID: 9585366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.